These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16110820)

  • 1. Nuances of new anti-Aspergillus antifungals.
    Perfect JR
    Med Mycol; 2005 May; 43 Suppl 1():S271-6. PubMed ID: 16110820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of drug-resistant Aspergillus infection.
    Aigner M; Lass-Flörl C
    Expert Opin Pharmacother; 2015; 16(15):2267-70. PubMed ID: 26328502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus--classification and antifungal susceptibilities.
    Buzina W
    Curr Pharm Des; 2013; 19(20):3615-28. PubMed ID: 23278534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of invasive aspergillosis for drug discovery.
    Paulussen C; Boulet GA; Cos P; Delputte P; Maes LJ
    Drug Discov Today; 2014 Sep; 19(9):1380-6. PubMed ID: 24931219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature.
    Kirby A; Hassan I; Burnie J
    J Infect; 2006 Jun; 52(6):405-14. PubMed ID: 16239033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus species intrinsically resistant to antifungal agents.
    Van Der Linden JW; Warris A; Verweij PE
    Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial strategies for combating invasive fungal infections.
    Spitzer M; Robbins N; Wright GD
    Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
    Snelders E; Melchers WJ; Verweij PE
    Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic study of drug-resistant Aspergillus and optimizing newer treatment].
    Izumikawa K
    Jpn J Antibiot; 2011 Feb; 64(1):27-34. PubMed ID: 21612041
    [No Abstract]   [Full Text] [Related]  

  • 11. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
    Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
    J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia.
    Peláez T; Álvarez-Pérez S; Mellado E; Serrano D; Valerio M; Blanco JL; Garcia ME; Muñoz P; Cuenca-Estrella M; Bouza E
    J Med Microbiol; 2013 Mar; 62(Pt 3):474-478. PubMed ID: 23161769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing in Aspergillus species complex.
    Lass-Flörl C
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():49-53. PubMed ID: 24372722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostics and susceptibility testing in Aspergillus.
    Bernal-Martínez L; Alastruey-Izquierdo A; Cuenca-Estrella M
    Future Microbiol; 2016; 11(2):315-28. PubMed ID: 26848512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of surgical debridement in different clinical manifestations of invasive aspergillosis.
    Reischies F; Hoenigl M
    Mycoses; 2014 Sep; 57 Suppl 2():1-14. PubMed ID: 25186615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on antifungal resistance in Aspergillus and Candida.
    Arendrup MC
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial aspergillosis in children successfully treated with antifungal therapy and surgical intervention.
    Giacchino M; Chiapello N; Riva C; Scolfaro C; Pultrone M; Valera M; Peretta P; Piglione M; Di Rosa G; Tovo PA
    Pediatr Infect Dis J; 2006 Apr; 25(4):379-81. PubMed ID: 16567999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
    Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
    J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental efficacy of anidulafungin against Aspergillus terreus species complex.
    Sanchis M; Capilla J; Mayayo E; Pastor FJ; Guarro J
    Med Mycol; 2015 Aug; 53(6):630-5. PubMed ID: 25980004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.
    Lionakis MS; Lewis RE; May GS; Wiederhold NP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2005 Apr; 191(7):1188-95. PubMed ID: 15747256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.